COVID-19 vaccine: Have the global markets priced it in? UBS tells where to invest
Updated : November 20, 2020 02:46 PM IST
Markets are likely to price the vaccine development in now before acknowledging logistical challenges, it further explained.
The brokerage estimates further 3-4 percent gains for Growth Indices and 6-7 percent for Value indices before the vaccine is fully priced in.